We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Qualcomm
QCOM
$176B
| $507K | 0.01% |
4,312
-64,672
| -94% | -$6.91M |
|
1427
Raymond James Financial
RJF
$32.5B
| $506K | 0.01% |
10,431
-41,609
| -80% | -$2.01M |
|
|
ADAP
1428
DELISTED
Adaptimmune Therapeutics
ADAP
| $505K | 0.01% |
+63,285
| New | +$554K |
|
1429
LoveSac
LOVE
$239M
| $505K | 0.01% |
18,220
-2,597
| -12% | -$73.8K |
|
1430
QuidelOrtho
QDEL
$1.09B
| $503K | 0.01% |
2,294
-4,326
| -65% | -$965K |
|
1431
Fate Therapeutics
FATE
$281M
| $502K | 0.01% |
12,553
-54,026
| -81% | -$1.89M |
|
1432
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $502K | 0.01% |
3,724
-157,130
| -98% | -$21.4M |
|
1433
Applied Industrial Technologies
AIT
$12.8B
| $501K | 0.01% |
9,096
+5,890
| +184% | +$360K |
|
1434
Lindsay Corp
LNN
$1.16B
| $501K | 0.01% |
5,183
-2,088
| -29% | -$206K |
|
|
CATM
1435
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $501K | 0.01% |
+25,300
| New | +$552K |
|
1436
Sportsman's Warehouse
SPWH
$43.7M
| $498K | 0.01% |
34,802
-36,598
| -51% | -$563K |
|
|
SRC
1437
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $498K | 0.01% |
+14,765
| New | +$515K |
|
1438
AudioCodes
AUDC
$244M
| $497K | 0.01% |
+15,808
| New | +$535K |
|
1439
Ezcorp Inc
EZPW
$1.82B
| $496K | 0.01% |
98,543
+35,468
| +56% | +$197K |
|
|
QTS
1440
DELISTED
QTS REALTY TRUST, INC.
QTS
| $496K | 0.01% |
+7,871
| New | +$525K |
|
1441
Arlo Technologies
ARLO
$1.4B
| $495K | 0.01% |
94,181
+12,784
| +16% | +$61.4K |
|
1442
Celldex Therapeutics
CLDX
$2.77B
| $495K | 0.01% |
+33,382
| New | +$391K |
|
1443
Zoetis
ZTS
$31.6B
| $495K | 0.01% |
2,991
-16,479
| -85% | -$2.53M |
|
|
CNSL
1444
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $495K | 0.01% |
86,999
+11,053
| +15% | +$76.7K |
|
|
MTEM
1445
DELISTED
Molecular Templates, Inc.
MTEM
| $494K | 0.01% |
3,018
-597
| -17% | -$106K |
|
1446
Macy's
M
$6.15B
| $493K | 0.01% |
+86,431
| New | +$576K |
|
1447
Canadian Solar
CSIQ
$906M
| $492K | 0.01% |
+14,027
| New | +$374K |
|
|
AFMD
1448
DELISTED
Affimed
AFMD
| $491K | 0.01% |
+14,471
| New | +$548K |
|
1449
Home BancShares
HOMB
$6.21B
| $491K | 0.01% |
+32,364
| New | +$520K |
|
1450
PUT
Comcast
CMCSA
$79.1B
| $490K | 0.01% |
10,600
+4,100
| +63% | +$178K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.